<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9375527</article-id>
    <article-id pub-id-type="doi">10.1093/database/baac064</article-id>
    <article-id pub-id-type="publisher-id">baac064</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database Tool</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ProbResist: a database for drug-resistant probiotic bacteria</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Dou</surname>
          <given-names>Wanying</given-names>
        </name>
        <aff><institution content-type="department">Department of Computer Science, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Abdalla</surname>
          <given-names>Hemn Barzan</given-names>
        </name>
        <aff><institution content-type="department">Department of Computer Science, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chen</surname>
          <given-names>Xu</given-names>
        </name>
        <aff><institution content-type="department">Department of Computer Science, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sun</surname>
          <given-names>Changyi</given-names>
        </name>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chen</surname>
          <given-names>Xuefei</given-names>
        </name>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tian</surname>
          <given-names>Qiwen</given-names>
        </name>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Junyi</given-names>
        </name>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Wei</given-names>
        </name>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chi</surname>
          <given-names>Wei</given-names>
        </name>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Xuan</given-names>
        </name>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ye</surname>
          <given-names>Hailv</given-names>
        </name>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bi</surname>
          <given-names>Chuyun</given-names>
        </name>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
        <aff><institution>Wenzhou Municipal Key Lab for Applied Biomedical and Biopharmaceutical Informatics</institution>, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
        <aff><institution>Zhejiang Bioinformatics International Science and Technology Cooperation Center</institution>, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tian</surname>
          <given-names>Xuechen</given-names>
        </name>
        <aff><institution>Wenzhou Municipal Key Lab for Applied Biomedical and Biopharmaceutical Informatics</institution>, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
        <aff><institution>Zhejiang Bioinformatics International Science and Technology Cooperation Center</institution>, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Yixin</given-names>
        </name>
        <aff><institution>Wenzhou Municipal Key Lab for Applied Biomedical and Biopharmaceutical Informatics</institution>, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
        <aff><institution>Zhejiang Bioinformatics International Science and Technology Cooperation Center</institution>, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9105-5845</contrib-id>
        <name>
          <surname>Wong</surname>
          <given-names>Aloysius</given-names>
        </name>
        <!--alwong@kean.edu-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Biology, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
        <aff><institution>Wenzhou Municipal Key Lab for Applied Biomedical and Biopharmaceutical Informatics</institution>, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
        <aff><institution>Zhejiang Bioinformatics International Science and Technology Cooperation Center</institution>, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
        <aff><institution content-type="department">Department of Computer Science, College of Science and Technology, Wenzhou-Kean University</institution>, 88 Daxue Road, Ouhai, Wenzhou, Zhejiang 325060, <country country="CN">China</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Corresponding author: Tel: +86 138 5771 3894; Fax: +86 577 5587 0494; Email: <email xlink:href="alwong@kean.edu">alwong@kean.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-08-13">
      <day>13</day>
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>13</day>
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <volume>2022</volume>
    <elocation-id>baac064</elocation-id>
    <history>
      <date date-type="received">
        <day>19</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>04</day>
        <month>7</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>06</day>
        <month>8</month>
        <year>2022</year>
      </date>
      <date date-type="editorial-decision">
        <day>29</day>
        <month>7</month>
        <year>2022</year>
      </date>
      <date date-type="corrected-typeset">
        <day>13</day>
        <month>8</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baac064.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Drug resistance remains a global threat, and the rising trend of consuming probiotic-containing foods, many of which harbor antibiotic resistant determinants, has raised serious health concerns. Currently, the lack of accessibility to location-, drug- and species-specific information of drug-resistant probiotics has hampered efforts to combat the global spread of drug resistance. Here, we describe the development of ProbResist, which is a manually curated online database that catalogs reports of probiotic bacteria that have been experimentally proven to be resistant to antibiotics. ProbResist allows users to search for information of drug resistance in probiotics by querying with the names of the bacteria, antibiotic or location. Retrieved results are presented in a downloadable table format containing the names of the antibiotic, probiotic species, resistant determinants, region where the study was conducted and digital article identifiers (PubMed Identifier and Digital Object Identifier) hyperlinked to the original sources. The webserver also presents a simple analysis of information stored in the database. Given the increasing reports of drug-resistant probiotics, an exclusive database is necessary to catalog them in one platform. It will enable medical practitioners and experts involved in policy making to access this information quickly and conveniently, thus contributing toward the broader goal of combating drug resistance.</p>
      <sec id="s2">
        <title>Database URL</title>
        <p><ext-link xlink:href="https://probresist.com" ext-link-type="uri">https://probresist.com</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Wenzhou-Kean University Student Partnering with Faculty (SpF) research program</institution>
          </institution-wrap>
        </funding-source>
        <award-id>WKU201920009, SpF2021002 and SpS2021029</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Zhejiang Bioinformatics International Science and Technology Cooperation Center</institution>
          </institution-wrap>
        </funding-source>
        <award-id>WB20210429000008</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Wenzhou Municipal Key Lab for Applied Biomedical and Biopharmaceutical Informatics</institution>
          </institution-wrap>
        </funding-source>
        <award-id>WB20211227000125</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="8"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s3">
    <title>Introduction</title>
    <p>Probiotics are live microorganisms that confer a broad range of health benefits to the host if consumed in adequate amounts (<xref rid="R1" ref-type="bibr">1</xref>). The health-promoting properties include modulating the immune system and treating inflammatory diseases (<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>), preventing cancer and acting as adjuvant for chemotherapy (<xref rid="R4" ref-type="bibr">4</xref>), treating viral respiratory infections (<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R6" ref-type="bibr">6</xref>), reducing low-density lipoprotein cholesterol and improving risk factors associated with coronary heart disease (<xref rid="R7" ref-type="bibr">7</xref>), eliciting beneficial metabolic effects in patients with type 2 diabetes mellitus and improving blood lipid profiles (<xref rid="R8" ref-type="bibr">8</xref>), assisting the treatment and management of oral diseases including halitosis, dental caries and periodontitis (<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>) as well as regulating anxiety, mood, cognition and pain, and treating and preventing neurologic disorders (<xref rid="R11" ref-type="bibr">11–13</xref>). As the health claims of probiotics continue to emerge, their number of applications also increases, as exemplified by the recent growth in the global probiotic market and the development of new probiotic-containing foods, supplements and health products (<xref rid="R14" ref-type="bibr">14–20</xref>). However, it is noted that in Europe, the European Food Safety Agency does not permit the term ‘probiotic’ to be used in foods and food supplements (<xref rid="R21" ref-type="bibr">21</xref>).</p>
    <p>There are overwhelming reports of probiotic bacteria isolated from various foods, animal and human samples that are resistant to antibiotics used in clinical and veterinary applications such as vancomycin, metronidazole, chloramphenicol, erythromycin, quinupristin/dalfopristin, lincomycin, clindamycin and tetracyclines (<xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R22" ref-type="bibr">22–25</xref>). Moreover, the resistant determinants responsible for the resistant phenotypes such as blaZ and mecA for beta-lactam antibiotics; aac(6′)-aph(2′′), ant(6) and aph(3′)-IIIa for aminoglycosides; erm(A), erm(B), erm(C), mefA and lnuA for erythromycin and tet(W), tet(L), tet(K), tet(S) and tet(M) for tetracycline have been characterized (<xref rid="R26" ref-type="bibr">26–33</xref>). While drug-resistant probiotics may not cause direct harm to humans, they can however transfer their resistant determinants not only to commensals but also to pathogens in the human gut or the oral cavity. Multiple studies have raised the concern that long-term consumption of foods containing drug-resistant probiotics will establish a reservoir of drug-resistant determinants in the gut or oral cavity, and risk acquisitions through horizontal gene transfer by opportunistic pathogens (<xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R33" ref-type="bibr">33–45</xref>). If so, it will render antibiotic treatments ineffective, thus exacerbating the problem of drug resistance in the clinical settings such as when recommending treatments for life-threatening diseases caused by pathogens, when treating immunocompromised patients or when performing surgical procedures (<xref rid="R46" ref-type="bibr">46–50</xref>).</p>
    <p>There is increasing evidence supporting the health risks of excessive or long-term consumption of drug-resistant probiotics. For instance, experimental evidence has demonstrated the conjugal transfer of resistant genes such as the erythromycin-resistant plasmid pLFE1 and tetracycline-resistance gene tet(M) from one probiotic strain to another of the same genus and crucially also to pathogenic strains such as <italic toggle="yes">Listeria innocua</italic>, <italic toggle="yes">Listeria monocytogenes</italic> and <italic toggle="yes">Enterococcus faecalis</italic> (<xref rid="R51" ref-type="bibr">51</xref>, <xref rid="R52" ref-type="bibr">52</xref>). In addition to in vitro filter mating studies, conjugal transfer of resistant genes from probiotics to pathogens in vivo, in the animal gut, and in fermentation stages during food processing, have also been reported (<xref rid="R32" ref-type="bibr">32</xref>). Recent evidence from metagenomics studies linking probiotic consumption to the increase in the number of resistant genes as well as the number of strains carrying the resistant genes has also been reported in mice and humans (<xref rid="R53" ref-type="bibr">53</xref>). Meanwhile, population genetic studies from selected Asian and European cohorts have also identified antibiotic-resistant genes in the human gut that are highly identical to known resistant genes of antibiotics widely used in animal husbandry (<xref rid="R54" ref-type="bibr">54</xref>). Notably, antibiotics from food and environmental sources were thought to have greater impact in establishing a reservoir of resistant genes in the human gut than antibiotics used in human medicine (<xref rid="R55" ref-type="bibr">55</xref>). Considering this evidence and given the projection that by 2050, more people will succumb to drug resistance-related illnesses than cancer (<xref rid="R56" ref-type="bibr">56</xref>), the health risk of drug-resistant probiotics has become even more concerning.</p>
    <p>Currently, the lack of accessibility to location-, drug- and organism-specific information of drug resistance in probiotic bacteria has hampered efforts to combat the global spread of drug resistance. Here, we built an online-based database that allows users to search for raw and processed information of drug resistance in probiotics quickly and conveniently, by querying with the names of the bacteria, antibiotic or location. A comprehensive catalog of drug-resistant probiotic bacteria can serve medical practitioners in providing better health care services including treatment, prescriptions and/or prevention advice to patients and inform experts involved in policy making, thus the development of ProbResist.</p>
  </sec>
  <sec id="s4">
    <title>Materials and methods</title>
    <sec id="s4-s1">
      <title>Selection of bacteria for inclusion in ProbResist database</title>
      <p>Relevant search terms such as ‘antibiotic resistance’, ‘drug resistance’, ‘probiotics’ and the combination thereof were used to search for articles reporting on drug-resistant probiotics from the PubMed database. In addition to the previous Lactobacillus genus name, the new names ‘Holzapfelia’, ‘Amylolactobacillus’, ‘Bombilactobacillus’, ‘Companilactobacillus’, ‘Lapidilactobacillus’, ‘Agrilactobacillus’, ‘Schleiferilactobacillus’, ‘Loigolactobacilus’, ‘Lacticaseibacillus’, ‘Latilactobacillus’, ‘Dellaglioa’, ‘Liquorilactobacillus’, ‘Ligilactobacillus’, ‘Lactiplantibacillus’, ‘Furfurilactobacillus’, ‘Paucilactobacillus’, ‘Limosilactobacillus’, ‘Fructilactobacillus’, ‘Acetilactobacillus’, ‘Apilactobacillus’, ‘Levilactobacillus’, ‘Secundilactobacillus’, ‘Lentilactobacillus’, ‘Lactobacillaceae’ and ‘Leuconostocaceae’ were also used as keywords together with the terms ‘antibiotic resistance’ or ‘drug resistance’, in our search (<xref rid="R57" ref-type="bibr">57</xref>) (<xref rid="s8" ref-type="sec">Supplementary Table S1</xref>). The retrieved articles were manually curated where, e.g. review articles were excluded to avoid overlapping reports of original research, before extracting information of probiotic strains reported, geographical location of study, antibiotics which were tested and the resistant genes, for inclusion in ProbResist database.</p>
    </sec>
    <sec id="s4-s2">
      <title>Information included in ProbResist database</title>
      <p>ProbResist database contains the drug-resistant probiotic strains, the geographical location where drug resistance was reported, the antibiotics which were tested, the source of the probiotic isolates and the nature of the resistant genes, if known. The article electronic identification numbers [PubMed Identifier (PMID) and Digital Object Identifier (DOI)] were also included in the database and hyperlinked to their original sources. An abbreviation legend of the bacteria names, e.g. Bb. = Bifidobacterium, Sc. = Streptococcus and W. = Weissela, was provided for easy referencing and clarity. The new names of Lactobacillus such as <italic toggle="yes">Lacticaseibacillus casei</italic> or <italic toggle="yes">Limosilactobacillus reuteri</italic> are spelled out in full. The database is periodically curated and updated to include new reports of drug-resistant probiotics.</p>
    </sec>
    <sec id="s4-s3">
      <title>ProbResist database construction and interface</title>
      <p>Search terms such as ‘antibiotic resistance’, ‘drug resistance’ and ‘probiotics’ and their combinations (see keywords under the section: selection of bacteria for inclusion in ProbResist database) were used to search for relevant reports from PubMed database, and the information, e.g. probiotic strains, location, source of the isolates, antibiotics, and nature of the resistant genes, was extracted to build the database for ProbResist. The extracted information is primally curated and formatted in Excel. The formatted sheet is then imported into MySQL database in the following format: antibiotic, species, gene location, source of isolates, the region or country where the study was conducted, and article electronic identification numbers (PMID and DOI). The front-end and back-end separation of the database website are programmed through a JavaScript Object Notation (JSON) format interface. The front-end is responsible for calling Asynchronous JavaScript and XML (AJAX) to fetch data and display, and the back-end provides Application Programming Interface (API) interface, and corresponding calculations. The back-end provides an interface to the front-end, and the front-end displays data according to the interface. When the user searches with the names of the probiotic species, antibiotic, or country, the front-end calls the database while the back-end provides the data in JSON format (<xref rid="F1" ref-type="fig">Figure 1</xref>). The web template from HTML design (<ext-link xlink:href="https://html.design" ext-link-type="uri">https://html.design</ext-link>) is adopted and modulated.</p>
      <fig position="float" id="F1" fig-type="figure">
        <label>Figure 1.</label>
        <caption>
          <p>ProbResist database and interface. Information extracted from articles retrieved from PubMed database was manually curated and formatted offline on Excel before importing into MySQL database in the following format: antibiotic, species, gene location, country, PMID and DOI. The database website structure was designed and developed using the front-end (blue box) and back-end (green box) separation where the website front-end will query the database when user invoked either the search function by species, antibiotic or country name, in the search bar. At the back-end, data are provided by restful web API in JSON format. For website development, an online web template provided by HTML design (<ext-link xlink:href="https://html.design" ext-link-type="uri">https://html.design</ext-link>) was adopted and modulated. Front-end only requires the setting up of the user query input as a parameter to specify API URL and then displayed in appropriate table HTML format. Users have the option to export their retrieved results into Excel format.</p>
        </caption>
        <graphic xlink:href="baac064f1" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="s5">
    <title>Results</title>
    <p>ProbResist is available at <ext-link xlink:href="https://probresist.com" ext-link-type="uri">https://probresist.com</ext-link> without registration or license. This database catalogs published reports of probiotic bacteria from various sources that have been experimentally proven to be resistant to one or more antibiotics. As ProbResist gathers relevant information in one website, it provides quick and convenient access to processed information on drug resistance in probiotics. In addition to the browse functions, the webserver also provides simple analysis of the database in graphical formats. Specifically, it presents (i) the breakdown of the type of probiotic bacteria most frequently reported to be resistant to antibiotics as pie chart, (ii) the abundance of antibiotic resistance reported in the scientific literature for probiotic bacteria as bar graph, (iii) the antibiotic classes, generations and mode of actions as tables and (iv) the frequency of reports of probiotics from different regions of countries that are resistant to antibiotics as heat map.</p>
    <p>The website features a top aligned white banner that houses the name of the database on the left and a browse full database tab on the right. Following the banner is a text search box accompanied by brief instructions that allow experienced users to quickly query and retrieve data from ProbResist. The Lactobacillus genus has been recently reclassified into more than 25 genera including 23 novel genera, thus newer articles (after April 2020) normally adopt these new names in their reports (<xref rid="R57" ref-type="bibr">57</xref>). To retrieve both the older and newer articles in the ProbResist database, specific instructions are provided on the website beneath the main search bar. Users can use the abbreviated forms of the bacteria, e.g. B. = Bacillus; Lb. = Lactobacillus when searching for older articles containing the previous Lactobacillus names but for newer articles, users are required to use the full names, e.g. <italic toggle="yes">Lacticaseibacillus casei</italic> or <italic toggle="yes">Limosilactobacillus reuteri</italic>. For convenience, a list of prominent Lactobacillus probiotic species and their new names, e.g. Lb. casei = <italic toggle="yes">Lacticaseibacillus casei</italic>; Lb. paracasei = <italic toggle="yes">Lacticaseibacillus paracasei</italic>; Lb. rhamnosus = <italic toggle="yes">Lacticaseibacillus rhamnosus</italic>; Lb. plantarum = <italic toggle="yes">Lactiplantibacillus plantarum</italic>; Lb. brevis = <italic toggle="yes">Levilactobacillus brevis</italic>; Lb. salivarius = <italic toggle="yes">Ligilactobacillus salivarius</italic>; Lb. fermentum = <italic toggle="yes">Limosilactobacillus fermentum</italic> and Lb. reuteri = <italic toggle="yes">Limosilactobacillus reuteri</italic>, is also provided. Direct links to the announcement by the International Scientific Association for Probiotics and Prebiotics (<ext-link xlink:href="https://isappscience.org/new-names-for-important-probiotic-lactobacillus-species/" ext-link-type="uri">https://isappscience.org/new-names-for-important-probiotic-lactobacillus-species/</ext-link>) and the published article (<xref rid="R57" ref-type="bibr">57</xref>) are also provided for those who wish to learn more about the Lactobacillus taxonomy changes. The search box allows users to query the database from three search options: antibiotic, species or region/country name. Since the database stores the abbreviated form of the bacteria, a legend of the abbreviated bacteria is provided beneath the search box for easy referencing (<xref rid="F2" ref-type="fig">Figure 2</xref>). To search for newer articles containing the new Lactobacillus names, their full forms must be used. The search box implements the autocomplete function with a drop-down menu containing text suggestions to aid users identify their search terms.</p>
    <fig position="float" id="F2" fig-type="figure">
      <label>Figure 2.</label>
      <caption>
        <p>Layout of the ProbResist webserver. (A) Top panel: screenshot of the home page beginning with a text search bar that allows experienced users to quickly query the database from three search options: bacteria species, antibiotic or region/country name. The search bar is accompanied by a detailed instruction and species abbreviation legend to aid user input. Following that, an introduction section containing a brief description of probiotics and antibiotic resistance is provided to aid first time users navigate and extract information from the database. Bottom panel: the next part of the webserver contains general information of the antibiotics as well as a brief analysis of the database organized based on the frequency of the respective species, drug resistance, antibiotic classes and region/country of study. (B) In the result page, retrieved results contain the name of antibiotic, bacteria species, gene name and location, source of isolates, country of study and the unique digital article identifiers PMID and DOI, hyperlinked to the original sources. The website allows users to export their results as Excel.</p>
      </caption>
      <graphic xlink:href="baac064f2" position="float"/>
    </fig>
    <p>Following the search box is the background information containing a description of probiotics and drug resistance to explain the nature and utility of the database in more detail, which aids first-time users navigate and extract information from the database. A ‘learn more’ tab beneath the background information links directly to selected articles, which provide users with more information from the literature regarding the health impact and recent developments of drug-resistant probiotics. Following the background information is a brief analysis section containing species, antibiotic resistance, antibiotic classes and geographical location, each represented by corresponding logos. This section allows user to assess processed information of ProbResist database in graphical formats such as the frequency of reports according to the bacteria species, drug resistance, antibiotic classes and geographical location. The website allows users to download the dataset of their searches in Excel format (<xref rid="F2" ref-type="fig">Figure 2</xref>).</p>
    <p>As of May 2022, ProbResist has 158 articles reporting on drug-resistant probiotics in its database. A brief analysis of the database metrics is provided on the website following the introduction section. In the analysis of resistant probiotic bacteria abundance in ProbResist database, Lactobacillus including their new names (744 times) is by far the largest group of probiotic bacteria reported to be resistant to antibiotics, followed by Bifidobacterium (81 times), Pediococcus (44 times), Weissela (36 times), Lactococcus (23 times), Streptococcus (18 times) and Bacillus (13 times), while the analysis of antibiotic types reported that probiotics resistant to tetracycline (91 times) is detected most frequently in the literature followed by erythromycin (70 times), vancomycin (63 times), streptomycin (60 times), chloramphenicol (47 times), kanamycin (40 times), ampicillin (37 times) and gentamicin (36 times). As for the analysis of the geographical distribution of reports on antibiotic-resistant probiotics, China, with 22 scientific articles, has the highest frequency of reports on antibiotic-resistant probiotics globally, followed by Belgium with 20, Italy with 19 and US and Spain, each with 10 articles, respectively (<xref rid="s8" ref-type="sec">Supplementary Table S1</xref>).</p>
    <p>In the result page, retrieved data are presented in a table containing the name of antibiotic, the bacteria species, the name of the resistant determinants and their locations whether on plasmids, transposons or chromosomes, the source of probiotic isolates, the region or country where the study was conducted, as well as the unique article identifiers PMID and DOI, with hyperlinks linking directly to the original sources (<xref rid="F2" ref-type="fig">Figure 2</xref>). The antibiotics, which probiotics are reported to be resistant to, are also hyperlinked to the antibiotic table containing information of the classes, generations and mode of actions. Above the table, a legend containing abbreviations of the bacteria names is provided and users are also reminded that the new names of Lactobacillus such as <italic toggle="yes">Lacticaseibacillus casei</italic> or <italic toggle="yes">Limosilactobacillus reuteri</italic> are spelled out in full in the database. At the bottom panel of the webserver is contact information as well as the current development status and planned updates of the webserver. Users have the option to export the retrieved results as Excel by clicking the ‘download all’ tab at the top of the table.</p>
  </sec>
  <sec id="s6">
    <title>Discussion</title>
    <p>Recent authoritative reviews on probiotic safety have also focused on the risk of probiotics in trafficking resistant determinants among other adverse effects such as causing systemic infections in immunocompromised individuals and deleterious metabolic activities (<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R34" ref-type="bibr">34–37</xref>, <xref rid="R43" ref-type="bibr">43</xref>, <xref rid="R58" ref-type="bibr">58–63</xref>). Antibiotics especially those from multiple classes such as penicillins, cephalosporins, sulfonamides and macrolides prescribed to infants have been associated with increased risk for allergy including food allergy, atopic and contact dermatitis, allergic rhinitis and allergic conjunctivitis, anaphylaxis and asthma, during the later stage of development. This is likely achieved through the disruption of the antibiotic-associated microbiome diversity (<xref rid="R64" ref-type="bibr">64</xref>, <xref rid="R65" ref-type="bibr">65</xref>). Indeed, it was shown in mice that antibiotic-associated reduction in intestinal microbiota and metabolic abundance such as short-chain fatty acids and tryptophan resulted in an increase in inflammatory response as evidenced by elevated immunoglobulins IgE and IgG1 after sensitization. Upon re-exposure to the allergens, the mice showed evidence for damaged intestinal barrier such as ruptured intestinal villi and a decrease in tight junction proteins (<xref rid="R66" ref-type="bibr">66</xref>). Thus, excessive or irresponsible use of probiotics, many of which are phenotypically resistant to clinically important antibiotics and harbor resistance genes on mobile genetic elements, could further exacerbate the current public health crisis especially in the clinical settings where those with underlying health conditions are most vulnerable. For instance, a meta-analysis study across 15 different countries revealed that diabetes mellitus has a significant association with multidrug-resistant tuberculosis (<xref rid="R67" ref-type="bibr">67</xref>), while patients with chronic kidney disease are likely to be the reservoir of antibiotic-resistant pathogens as multidrug-resistant organisms such as vancomycin-resistant enterococci or methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> are prevalent in these individuals (<xref rid="R68" ref-type="bibr">68</xref>). On the other hand, drug-resistant human immunodeficiency virus (HIV) is already recognized as an emerging threat to epidemic control since HIV patients more frequently contract opportunistic infections including tuberculosis and have higher risk for Coronavirus Disease 2019 (COVID-19) mortality (<xref rid="R69" ref-type="bibr">69–71</xref>).</p>
    <p>To our knowledge, ProbResist is the first and most comprehensive webtool to catalog probiotic bacteria globally that have been reported to be resistant to antibiotics. Since drug-resistant probiotics are relatively understudied compared to clinically relevant or disease-causing strains, a more focused probiotic-specific database would allow this increasingly popular group of bacteria to be highlighted especially since there is increasing demand corresponding to the rising trend of dietary, health and food supplement use (<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R62" ref-type="bibr">62–74</xref>). The latter contains the highest amount of probiotic bacteria per serving compared to other foods, and recent reports of drug resistance in probiotics from health supplements further exacerbate its health concerns (<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R34" ref-type="bibr">34</xref>, <xref rid="R35" ref-type="bibr">35</xref>). Due to its fungal nature, yeast such as <italic toggle="yes">Saccharomyces boulardii</italic> is intrinsically resistant to antibiotics and is already shown to exhibit some probiotic properties such as alleviating infections in the gut. Thus, as alternatives to lactic acid bacteria, commensal fungal species could be further explored and developed using modern genetic engineering methods to produce effective and safer probiotics (<xref rid="R75" ref-type="bibr">75</xref>, <xref rid="R76" ref-type="bibr">76</xref>).</p>
    <p>ProbResist is an initial effort to catalog probiotic bacteria that have been reported in scholarly articles to be resistant to drugs. Since this database only includes reports from published articles cataloged in PubMed, it will require a community-driven effort to make this database as comprehensive as possible as more localized reports and community hospital data especially those in the developing and underdeveloped countries, remain unpublished. As such, users are encouraged to reach us through the email provided at the bottom of the webpage to propose unreported drug-resistant probiotics that warrant inclusion in our database and our team will validate the request and update the database accordingly. Additionally, we are also exploring other repositories to identify more reports of drug-resistant probiotics and conduct periodic updates on the database as new experimental evidence surface.</p>
  </sec>
  <sec id="s7">
    <title>Conclusion</title>
    <p>Given the increasing number of reported drug-resistant probiotics (<xref rid="R77" ref-type="bibr">77</xref>, <xref rid="R78" ref-type="bibr">78</xref>), an exclusive database is therefore necessary to organize reports of drug-resistant probiotics in one platform, which enables health professionals, medical practitioners and experts involved in policy making, to quickly and conveniently search for, and assess the processed forms of, this information. The increasing connectivity especially in developing countries also enables our webserver to contribute towards the broader goal of combating antibiotic resistance.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>baac064_Supp</label>
      <media xlink:href="baac064_supp.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We acknowledge the administrative, technical and logistical support provided by Wenzhou Municipal Key Lab for Applied Biomedical and Biopharmaceutical Informatics and Zhejiang Bioinformatics International Science and Technology Cooperation Center, headed by Y.Y.</p>
  </ack>
  <sec id="s8">
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Database</italic> Online.</p>
  </sec>
  <sec id="s9">
    <title>Author contributions</title>
    <p>Conceptualization, A.W.; methodology, A.W., W.D. and H.B.A.; formal analysis, A.W. and W.D., investigation, A.W., W.D., Xu.C., C.S., Xue.C., Q.T. and J.Y.; resources, A.W., X.Z., H.Y., C.B., X.T. and Y.Y.; data curation, A.W., W.D., C.S., Xue.C., Q.T., J.Y., X.Z. and H.Y.; writing—original draft preparation, A.W., W.D., C.B. and H.B.A.; writing—review and editing, A.W., X.T. and Y.Y.; supervision, A.W., H.B.A., X.T. and Y.Y.; project administration, A.W., X.Z., H.Y. C.B. and X.T.; funding acquisition, A.W., H.Y., X.T. and Y.Y. All authors have read and agreed to the published version of the manuscript.</p>
  </sec>
  <sec id="s10">
    <title>Funding</title>
    <p>Wenzhou-Kean University Student Partnering with Faculty (SpF) research program (SpF2021002, SpS2021029 and WKU201920009) awarded to A.W. and H.Y.; Wenzhou Municipal Key Lab for Applied Biomedical and Biopharmaceutical Informatics (WB20211227000125); Zhejiang Bioinformatics International Science and Technology Cooperation Center (WB20210429000008) headed by Y.Y.</p>
  </sec>
  <sec id="s11">
    <title>Conflict of interest</title>
    <p>The authors declare that there is no conflict of interest.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mackowiak</surname><given-names>P.A.</given-names></string-name></person-group> (<year>2013</year>) <article-title>Recycling metchnikoff: probiotics, the intestinal microbiome and the quest for long life</article-title>. <source><italic toggle="yes">Front. Public Health</italic></source>, <volume>1</volume>, <page-range>52</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fpubh.2013.00052</pub-id>.</mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klaenhammer</surname><given-names>T.R.</given-names></string-name>, <string-name><surname>Kleerebezem</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kopp</surname><given-names>M.V.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>The impact of probiotics and prebiotics on the immune system</article-title>. <source><italic toggle="yes">Nat. Rev. Immunol.</italic></source>, <volume>12</volume>, <fpage>728</fpage>–<lpage>734</lpage>.doi: <pub-id pub-id-type="doi">10.1038/nri3312</pub-id>.<pub-id pub-id-type="pmid">23007572</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maldonado Galdeano</surname><given-names>C.</given-names></string-name>, <string-name><surname>Cazorla</surname><given-names>S.I.</given-names></string-name>, <string-name><surname>Lemme Dumit</surname><given-names>J.M.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>Beneficial effects of probiotic consumption on the immune system</article-title>. <source><italic toggle="yes">Ann. Nutr. Metab.</italic></source>, <volume>74</volume>, <fpage>115</fpage>–<lpage>124</lpage>.doi: <pub-id pub-id-type="doi">10.1159/000496426</pub-id>.<pub-id pub-id-type="pmid">30673668</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Śliżewska</surname><given-names>K.</given-names></string-name>, <string-name><surname>Markowiak-Kopeć</surname><given-names>P.</given-names></string-name> and <string-name><surname>Śliżewska</surname><given-names>W.</given-names></string-name></person-group> (<year>2020</year>) <article-title>The role of probiotics in cancer prevention</article-title>. <source><italic toggle="yes">Cancers (Basel)</italic></source>, <volume>13</volume>, <page-range>20</page-range>.doi: <pub-id pub-id-type="doi">10.3390/cancers13010020</pub-id>.</mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shahbazi</surname><given-names>R.</given-names></string-name>, <string-name><surname>Yasavoli-Sharahi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Alsadi</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Probiotics in treatment of viral respiratory infections and neuroinflammatory disorders</article-title>. <source><italic toggle="yes">Molecules</italic></source>, <volume>25</volume>, <page-range>4891</page-range>.doi: <pub-id pub-id-type="doi">10.3390/molecules25214891</pub-id>.</mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Oliveira</surname><given-names>G.L.V.</given-names></string-name>, <string-name><surname>Oliveira</surname><given-names>C.N.S.</given-names></string-name>, <string-name><surname>Pinzan</surname><given-names>C.F.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Microbiota modulation of the gut-lung axis in COVID-19</article-title>. <source><italic toggle="yes">Front. Immunol.</italic></source>, <volume>12</volume>, <page-range>635471</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.635471</pub-id>.</mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>DiRienzo</surname><given-names>D.B.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets</article-title>. <source><italic toggle="yes">Nutr. Rev.</italic></source>, <volume>72</volume>, <fpage>18</fpage>–<lpage>29</lpage>.doi: <pub-id pub-id-type="doi">10.1111/nure.12084</pub-id>.<pub-id pub-id-type="pmid">24330093</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kocsis</surname><given-names>T.</given-names></string-name>, <string-name><surname>Molnár</surname><given-names>B.</given-names></string-name>, <string-name><surname>Németh</surname><given-names>D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials</article-title>. <source><italic toggle="yes">Sci. Rep.</italic></source>, <volume>10</volume>, <page-range>11787</page-range>.doi: <pub-id pub-id-type="doi">10.1038/s41598-020-68440-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alshareef</surname><given-names>A.</given-names></string-name>, <string-name><surname>Attia</surname><given-names>A.</given-names></string-name>, <string-name><surname>Almalki</surname><given-names>M.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Effectiveness of probiotic lozenges in periodontal management of chronic periodontitis patients: clinical and immunological study</article-title>. <source><italic toggle="yes">Eur. J. Dent.</italic></source>, <volume>14</volume>, <fpage>281</fpage>–<lpage>287</lpage>.doi: <pub-id pub-id-type="doi">10.1055/s-0040-1709924</pub-id>.<pub-id pub-id-type="pmid">32438428</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bustamante</surname><given-names>M.</given-names></string-name>, <string-name><surname>Oomah</surname><given-names>B.D.</given-names></string-name>, <string-name><surname>Mosi-Roa</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Probiotics as an adjunct therapy for the treatment of halitosis, dental caries and periodontitis</article-title>. <source><italic toggle="yes">Probiotics Antimicrob. Proteins</italic></source>, <volume>12</volume>, <fpage>325</fpage>–<lpage>334</lpage>.doi: <pub-id pub-id-type="doi">10.1007/s12602-019-9521-4</pub-id>.<pub-id pub-id-type="pmid">30729452</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cryan</surname><given-names>J.F.</given-names></string-name> and <string-name><surname>Dinan</surname><given-names>T.G.</given-names></string-name></person-group> (<year>2012</year>) <article-title>Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour</article-title>. <source><italic toggle="yes">Nat. Rev. Neurosci.</italic></source>, <volume>13</volume>, <fpage>701</fpage>–<lpage>712</lpage>.doi: <pub-id pub-id-type="doi">10.1038/nrn3346</pub-id>.<pub-id pub-id-type="pmid">22968153</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Umbrello</surname><given-names>G.</given-names></string-name> and <string-name><surname>Esposito</surname><given-names>S.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Microbiota and neurologic diseases: potential effects of probiotics</article-title>. <source><italic toggle="yes">J. Transl. Med.</italic></source>, <volume>14</volume>, <page-range>298</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s12967-016-1058-7</pub-id>.</mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salami</surname><given-names>M.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Interplay of good bacteria and central nervous system: cognitive aspects and mechanistic considerations</article-title>. <source><italic toggle="yes">Front. Neurosci.</italic></source>, <volume>15</volume>, <page-range>613120</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fnins.2021.613120</pub-id>.</mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rijkers</surname><given-names>G.T.</given-names></string-name>, <string-name><surname>de Vos</surname><given-names>W.M.</given-names></string-name>, <string-name><surname>Brummer</surname><given-names>R.J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2011</year>) <article-title>Health benefits and health claims of probiotics: bridging science and marketing</article-title>. <source><italic toggle="yes">Br. J. Nutr.</italic></source>, <volume>106</volume>, <fpage>1291</fpage>–<lpage>1296</lpage>.doi: <pub-id pub-id-type="doi">10.1017/S000711451100287X</pub-id>.<pub-id pub-id-type="pmid">21861940</pub-id></mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kamiński</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kręgielska-Narożna</surname><given-names>M.</given-names></string-name> and <string-name><surname>Bogdański</surname><given-names>P.</given-names></string-name></person-group> (<year>2000</year>) <article-title>Determination of the popularity of dietary supplements using Google search rankings</article-title>. <source><italic toggle="yes">Nutrients</italic></source>, <volume>12</volume>, <page-range>908</page-range>.doi: <pub-id pub-id-type="doi">10.3390/nu12040908</pub-id>.</mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wong</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ngu</surname><given-names>D.Y.</given-names></string-name>, <string-name><surname>Dan</surname><given-names>L.A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2015</year>) <article-title>Detection of antibiotic resistance in probiotics of dietary supplements</article-title>. <source><italic toggle="yes">Nutr. J.</italic></source>, <volume>14</volume>, <page-range>95</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s12937-015-0084-2</pub-id>.</mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Tian</surname><given-names>X.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Assessing the risk of probiotic dietary supplements in the context of antibiotic resistance</article-title>. <source><italic toggle="yes">Front. Microbiol.</italic></source>, <volume>8</volume>, <page-range>908</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fmicb.2017.00908</pub-id>.</mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagpal</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kumar</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kumar</surname><given-names>M.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Probiotics, their health benefits and applications for developing healthier foods: a review</article-title>. <source><italic toggle="yes">FEMS Microbiol. Lett.</italic></source>, <volume>334</volume>, <fpage>1</fpage>–<lpage>15</lpage>.doi: <pub-id pub-id-type="doi">10.1111/j.1574-6968.2012.02593.x</pub-id>.<pub-id pub-id-type="pmid">22568660</pub-id></mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kechagia</surname><given-names>M.</given-names></string-name>, <string-name><surname>Basoulis</surname><given-names>D.</given-names></string-name>, <string-name><surname>Konstantopoulou</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>Health benefits of probiotics: a review</article-title>. <source><italic toggle="yes">ISRN Nutri.</italic></source>, <volume>2013</volume>, <page-range>481651</page-range>.doi: <pub-id pub-id-type="doi">10.5402/2013/481651</pub-id>.</mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gungor</surname><given-names>O.E.</given-names></string-name>, <string-name><surname>Kirzioglu</surname><given-names>Z.</given-names></string-name> and <string-name><surname>Kivanc</surname><given-names>M.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Probiotics: can they be used to improve oral health?</article-title><source><italic toggle="yes">Benef. Microbes</italic></source>, <volume>6</volume>, <fpage>647</fpage>–<lpage>656</lpage>.doi: <pub-id pub-id-type="doi">10.3920/BM2014.0167</pub-id>.<pub-id pub-id-type="pmid">26123783</pub-id></mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Simone</surname><given-names>C.</given-names></string-name></person-group> (<year>2019</year>) <article-title>The unregulated probiotic market</article-title>. <source><italic toggle="yes">Clin. Gastroenterol. Hepatol.</italic></source>, <volume>17</volume>, <fpage>809</fpage>–<lpage>817</lpage>.doi: <pub-id pub-id-type="doi">10.1016/j.cgh.2018.01.018</pub-id>.<pub-id pub-id-type="pmid">29378309</pub-id></mixed-citation>
    </ref>
    <ref id="R22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abriouel</surname><given-names>H.</given-names></string-name>, <string-name><surname>Casado Muñoz</surname><given-names>M.D.C.</given-names></string-name>, <string-name><surname>Lavilla Lerma</surname><given-names>L.</given-names></string-name></person-group><etal>et al.</etal> (<year>2015</year>) <article-title>New insights in antibiotic resistance of Lactobacillus species from fermented foods</article-title>. <source><italic toggle="yes">Food Res. Int.</italic></source>, <volume>78</volume>, <fpage>465</fpage>–<lpage>481</lpage>.doi: <pub-id pub-id-type="doi">10.1016/j.foodres.2015.09.016</pub-id>.<pub-id pub-id-type="pmid">28433315</pub-id></mixed-citation>
    </ref>
    <ref id="R23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shazali</surname><given-names>N.</given-names></string-name>, <string-name><surname>Foo</surname><given-names>H.L.</given-names></string-name>, <string-name><surname>Loh</surname><given-names>T.C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Prevalence of antibiotic resistance in lactic acid bacteria isolated from the faeces of broiler chicken in Malaysia</article-title>. <source><italic toggle="yes">Gut Pathog</italic></source>, <volume>6</volume>, <page-range>1</page-range>.doi: <pub-id pub-id-type="doi">10.1186/1757-4749-6-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="R24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sirichoat</surname><given-names>A.</given-names></string-name>, <string-name><surname>Flórez</surname><given-names>A.B.</given-names></string-name>, <string-name><surname>Vázquez</surname><given-names>L.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Antibiotic susceptibility profiles of lactic acid bacteria from the human vagina and genetic basis of acquired resistances</article-title>. <source><italic toggle="yes">Int. J. Mol. Sci.</italic></source>, <volume>21</volume>, <page-range>2594</page-range>.doi: <pub-id pub-id-type="doi">10.3390/ijms21072594</pub-id>.</mixed-citation>
    </ref>
    <ref id="R25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sharma</surname><given-names>P.</given-names></string-name>, <string-name><surname>Tomar</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Goswami</surname><given-names>P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Antibiotic resistance among commercially available probiotics</article-title>. <source><italic toggle="yes">Food Res. Int.</italic></source>, <volume>57</volume>, <fpage>176</fpage>–<lpage>195</lpage>.doi: <pub-id pub-id-type="doi">10.1016/j.foodres.2014.01.025</pub-id>.</mixed-citation>
    </ref>
    <ref id="R26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aquilanti</surname><given-names>L.</given-names></string-name>, <string-name><surname>Garofalo</surname><given-names>C.</given-names></string-name>, <string-name><surname>Osimani</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2007</year>) <article-title>Isolation and molecular characterization of antibiotic-resistant lactic acid bacteria from poultry and swine meat products</article-title>. <source><italic toggle="yes">J. Food Prot.</italic></source>, <volume>70</volume>, <fpage>557</fpage>–<lpage>565</lpage>.doi: <pub-id pub-id-type="doi">10.4315/0362-028X-70.3.557</pub-id>.<pub-id pub-id-type="pmid">17388042</pub-id></mixed-citation>
    </ref>
    <ref id="R27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anisimova</surname><given-names>E.A.</given-names></string-name> and <string-name><surname>Yarullina</surname><given-names>D.R.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Antibiotic resistance of LACTOBACILLUS strains</article-title>. <source><italic toggle="yes">Curr. Microbiol.</italic></source>, <volume>76</volume>, <fpage>1407</fpage>–<lpage>1416</lpage>.doi: <pub-id pub-id-type="doi">10.1007/s00284-019-01769-7</pub-id>.<pub-id pub-id-type="pmid">31555856</pub-id></mixed-citation>
    </ref>
    <ref id="R28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Çataloluk</surname><given-names>O.</given-names></string-name> and <string-name><surname>Gogebakan</surname><given-names>B.</given-names></string-name></person-group> (<year>2004</year>) <article-title>Presence of drug resistance in intestinal lactobacilli of dairy and human origin in Turkey</article-title>. <source><italic toggle="yes">FEMS Microbiol. Lett.</italic></source>, <volume>236</volume>, <fpage>7</fpage>–<lpage>12</lpage>.doi: <pub-id pub-id-type="doi">10.1111/j.1574-6968.2004.tb09620.x</pub-id>.<pub-id pub-id-type="pmid">15212784</pub-id></mixed-citation>
    </ref>
    <ref id="R29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Casado Muñoz Mdel</surname><given-names>C.</given-names></string-name>, <string-name><surname>Benomar</surname><given-names>N.</given-names></string-name>, <string-name><surname>Lerma</surname><given-names>L.L.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Antibiotic resistance of Lactobacillus pentosus and Leuconostoc pseudomesenteroides isolated from naturally-fermented Aloreña table olives throughout fermentation process</article-title>. <source><italic toggle="yes">Int. J. Food Microbiol.</italic></source>, <volume>172</volume>, <fpage>110</fpage>–<lpage>118</lpage>.doi: <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2013.11.025</pub-id>.<pub-id pub-id-type="pmid">24370969</pub-id></mixed-citation>
    </ref>
    <ref id="R30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klare</surname><given-names>I.</given-names></string-name>, <string-name><surname>Konstabel</surname><given-names>C.</given-names></string-name>, <string-name><surname>Werner</surname><given-names>G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2007</year>) <article-title>Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use</article-title>. <source><italic toggle="yes">J. Antimicrob. Chemother.</italic></source>, <volume>59</volume>, <fpage>900</fpage>–<lpage>912</lpage>.doi: <pub-id pub-id-type="doi">10.1093/jac/dkm035</pub-id>.<pub-id pub-id-type="pmid">17369278</pub-id></mixed-citation>
    </ref>
    <ref id="R31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dec</surname><given-names>M.</given-names></string-name>, <string-name><surname>Urban-Chmiel</surname><given-names>R.</given-names></string-name>, <string-name><surname>Stępień-Pyśniak</surname><given-names>D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Assessment of antibiotic susceptibility in Lactobacillus isolates from chickens</article-title>. <source><italic toggle="yes">Gut Pathog</italic></source>, <volume>9</volume>, <page-range>54</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s13099-017-0203-z</pub-id>.</mixed-citation>
    </ref>
    <ref id="R32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thumu</surname><given-names>S.C.</given-names></string-name> and <string-name><surname>Halami</surname><given-names>P.M.</given-names></string-name></person-group> (<year>2012</year>) <article-title>Presence of erythromycin and tetracycline resistance genes in lactic acid bacteria from fermented foods of Indian origin</article-title>. <source><italic toggle="yes">Antonie Van Leeuwenhoek</italic></source>, <volume>102</volume>, <fpage>541</fpage>–<lpage>551</lpage>.doi: <pub-id pub-id-type="doi">10.1007/s10482-012-9749-4</pub-id>.<pub-id pub-id-type="pmid">22644346</pub-id></mixed-citation>
    </ref>
    <ref id="R33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gueimonde</surname><given-names>M.</given-names></string-name>, <string-name><surname>Sánchez</surname><given-names>B.</given-names></string-name>, <string-name><surname>de Los Reyes-gavilán</surname><given-names>C.G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>Antibiotic resistance in probiotic bacteria</article-title>. <source><italic toggle="yes">Front. Microbiol.</italic></source>, <volume>4</volume>, <page-range>202</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fmicb.2013.00202</pub-id>.</mixed-citation>
    </ref>
    <ref id="R34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Probiotic supplements: hope or hype?</article-title>. <source><italic toggle="yes">Front. Microbiol.</italic></source>, <volume>11</volume>, <page-range>160</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.00160</pub-id>.</mixed-citation>
    </ref>
    <ref id="R35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kothari</surname><given-names>D.</given-names></string-name>, <string-name><surname>Patel</surname><given-names>S.</given-names></string-name> and <string-name><surname>Kim</surname><given-names>S.K.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Probiotic supplements might not be universally-effective and safe: a review</article-title>. <source><italic toggle="yes">Biomed. Pharmacother.</italic></source>, <volume>111</volume>, <fpage>537</fpage>–<lpage>547</lpage>.doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2018.12.104</pub-id>.<pub-id pub-id-type="pmid">30597307</pub-id></mixed-citation>
    </ref>
    <ref id="R36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>T.</given-names></string-name>, <string-name><surname>Teng</surname><given-names>D.</given-names></string-name>, <string-name><surname>Mao</surname><given-names>R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>A critical review of antibiotic resistance in probiotic bacteria</article-title>. <source><italic toggle="yes">Food Res. Int.</italic></source>, <volume>136</volume>, <page-range>109571</page-range>.doi: <pub-id pub-id-type="doi">10.1016/j.foodres.2020.109571</pub-id>.</mixed-citation>
    </ref>
    <ref id="R37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jose</surname><given-names>N.M.</given-names></string-name>, <string-name><surname>Bunt</surname><given-names>C.R.</given-names></string-name> and <string-name><surname>Hussain</surname><given-names>M.A.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Implications of antibiotic resistance in probiotics</article-title>. <source><italic toggle="yes">Food Rev. Int.</italic></source>, <volume>31</volume>, <fpage>52</fpage>–<lpage>62</lpage>.doi: <pub-id pub-id-type="doi">10.1080/87559129.2014.961075</pub-id>.</mixed-citation>
    </ref>
    <ref id="R38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Broaders</surname><given-names>E.</given-names></string-name>, <string-name><surname>Gahan</surname><given-names>C.G.</given-names></string-name> and <string-name><surname>Marchesi</surname><given-names>J.R.</given-names></string-name></person-group> (<year>2013</year>) <article-title>Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes</article-title>. <source><italic toggle="yes">Gut Microbes</italic></source>, <volume>4</volume>, <fpage>271</fpage>–<lpage>280</lpage>.doi: <pub-id pub-id-type="doi">10.4161/gmic.24627</pub-id>.<pub-id pub-id-type="pmid">23651955</pub-id></mixed-citation>
    </ref>
    <ref id="R39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Penders</surname><given-names>J.</given-names></string-name>, <string-name><surname>Stobberingh</surname><given-names>E.E.</given-names></string-name>, <string-name><surname>Savelkoul</surname><given-names>P.H.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>The human microbiome as a reservoir of antimicrobial resistance</article-title>. <source><italic toggle="yes">Front. Microbiol.</italic></source>, <volume>4</volume>, <page-range>87</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fmicb.2013.00087</pub-id>.</mixed-citation>
    </ref>
    <ref id="R40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rolain</surname><given-names>J.M.</given-names></string-name></person-group> (<year>2013</year>) <article-title>Food and human gut as reservoirs of transferable antibiotic resistance encoding genes</article-title>. <source><italic toggle="yes">Front. Microbiol.</italic></source>, <volume>4</volume>, <page-range>173</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fmicb.2013.00173</pub-id>.</mixed-citation>
    </ref>
    <ref id="R41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van Schaik</surname><given-names>W.</given-names></string-name></person-group> (<year>2015</year>) <article-title>The human gut resistome</article-title>. <source><italic toggle="yes">Philos. Trans. R Soc. Lond. B Biol. Sci.</italic></source>, <volume>370</volume>, <page-range>20140087</page-range>.doi: <pub-id pub-id-type="doi">10.1098/rstb.2014.0087</pub-id>.</mixed-citation>
    </ref>
    <ref id="R42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Imperial</surname><given-names>I.C.</given-names></string-name> and <string-name><surname>Ibana</surname><given-names>J.A.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Addressing the antibiotic resistance problem with probiotics: reducing the risk of its double-edged sword effect</article-title>. <source><italic toggle="yes">Front. Microbiol.</italic></source>, <volume>7</volume>, <page-range>1983</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fmicb.2016.01983</pub-id>.</mixed-citation>
    </ref>
    <ref id="R43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chon</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Seo</surname><given-names>K.H.</given-names></string-name>, <string-name><surname>Bae</surname><given-names>D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Status and prospect of lactic acid bacteria with antibiotic resistance</article-title>. <source><italic toggle="yes">J. Dairy Sci. Biotechnol.</italic></source>, <volume>38</volume>, <fpage>70</fpage>–<lpage>88</lpage>.doi: <pub-id pub-id-type="doi">10.22424/jdsb.2020.38.2.70</pub-id>.</mixed-citation>
    </ref>
    <ref id="R44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Dong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2022</year>) <article-title>Assessing the drug resistance profiles of oral probiotic lozenges</article-title>. <source><italic toggle="yes">J. Oral Microbiol.</italic></source>, <volume>14</volume>, <page-range>2019992</page-range>.doi: <pub-id pub-id-type="doi">10.1080/20002297.2021.2019992</pub-id>.</mixed-citation>
    </ref>
    <ref id="R45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wong</surname><given-names>A.</given-names></string-name>, <string-name><surname>Matijasic</surname><given-names>B.B.</given-names></string-name>, <string-name><surname>Ibana</surname><given-names>J.A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2022</year>) <article-title>Editorial: antimicrobial resistance along the food chain: are we what we eat?</article-title><source><italic toggle="yes">Front. Microbiol</italic></source>, <volume>13</volume>, <page-range>881882</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fmicb.2022.881882</pub-id>.</mixed-citation>
    </ref>
    <ref id="R46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Avershina</surname><given-names>E.</given-names></string-name>, <string-name><surname>Shapovalova</surname><given-names>V.</given-names></string-name> and <string-name><surname>Shipulin</surname><given-names>G.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Fighting antibiotic resistance in hospital-acquired infections: current state and emerging technologies in disease prevention, diagnostics and therapy</article-title>. <source><italic toggle="yes">Front. Microbiol.</italic></source>, <volume>12</volume>, <page-range>707330</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.707330</pub-id>.</mixed-citation>
    </ref>
    <ref id="R47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>R.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>B.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Drug resistance of pathogens causing nosocomial infection in orthopedics from 2012 to 2017: a 6-year retrospective study</article-title>. <source><italic toggle="yes">J. Orthop. Surg. Res.</italic></source>, <volume>16</volume>, <page-range>100</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s13018-021-02234-7</pub-id>.</mixed-citation>
    </ref>
    <ref id="R48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Calligaro</surname><given-names>G.L.</given-names></string-name>, <string-name><surname>Moodley</surname><given-names>L.</given-names></string-name>, <string-name><surname>Symons</surname><given-names>G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>The medical and surgical treatment of drug-resistant tuberculosis</article-title>. <source><italic toggle="yes">J. Thorac. Dis.</italic></source>, <volume>6</volume>, <fpage>186</fpage>–<lpage>195</lpage>.doi: <pub-id pub-id-type="doi">10.3978/j.issn.2072-1439.2013.11.11</pub-id>.<pub-id pub-id-type="pmid">24624282</pub-id></mixed-citation>
    </ref>
    <ref id="R49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Prestinaci</surname><given-names>F.</given-names></string-name>, <string-name><surname>Pezzotti</surname><given-names>P.</given-names></string-name> and <string-name><surname>Pantosti</surname><given-names>A.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Antimicrobial resistance: a global multifaceted phenomenon</article-title>. <source><italic toggle="yes">Pathog. Glob. Health.</italic></source>, <volume>109</volume>, <fpage>309</fpage>–<lpage>318</lpage>.doi: <pub-id pub-id-type="doi">10.1179/2047773215Y.0000000030</pub-id>.<pub-id pub-id-type="pmid">26343252</pub-id></mixed-citation>
    </ref>
    <ref id="R50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Choo</surname><given-names>E.J.</given-names></string-name> and <string-name><surname>Chambers</surname><given-names>H.F.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Treatment of methicillin-resistant Staphylococcus aureus bacteremia</article-title>. <source><italic toggle="yes">Infect. Chemother.</italic></source>, <volume>48</volume>, <fpage>267</fpage>–<lpage>273</lpage>.doi: <pub-id pub-id-type="doi">10.3947/ic.2016.48.4.267</pub-id>.<pub-id pub-id-type="pmid">28032484</pub-id></mixed-citation>
    </ref>
    <ref id="R51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Devirgiliis</surname><given-names>C.</given-names></string-name>, <string-name><surname>Coppola</surname><given-names>D.</given-names></string-name>, <string-name><surname>Barile</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2009</year>) <article-title>Characterization of the Tn916 conjugative transposon in a food-borne strain of <italic toggle="yes">Lactobacillus paracasei</italic></article-title>. <source><italic toggle="yes">Appl. Environ. Microbiol.</italic></source>, <volume>75</volume>, <fpage>3866</fpage>–<lpage>3871</lpage>.doi: <pub-id pub-id-type="doi">10.1128/AEM.00589-09</pub-id>.<pub-id pub-id-type="pmid">19395574</pub-id></mixed-citation>
    </ref>
    <ref id="R52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feld</surname><given-names>L.</given-names></string-name>, <string-name><surname>Schjørring</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hammer</surname><given-names>K.</given-names></string-name></person-group><etal>et al.</etal> (<year>2008</year>) <article-title>Selective pressure affects transfer and establishment of a <italic toggle="yes">Lactobacillus plantarum</italic> resistance plasmid in the gastrointestinal environment</article-title>. <source><italic toggle="yes">J. Antimicrob. Chemother.</italic></source>, <volume>61</volume>, <fpage>845</fpage>–<lpage>852</lpage>.doi: <pub-id pub-id-type="doi">10.1093/jac/dkn033</pub-id>.<pub-id pub-id-type="pmid">18238887</pub-id></mixed-citation>
    </ref>
    <ref id="R53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Montassier</surname><given-names>E.</given-names></string-name>, <string-name><surname>Valdés-Mas</surname><given-names>R.</given-names></string-name>, <string-name><surname>Batard</surname><given-names>E.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner</article-title>. <source><italic toggle="yes">Nat. Microbiol.</italic></source>, <volume>6</volume>, <fpage>1043</fpage>–<lpage>1054</lpage>.doi: <pub-id pub-id-type="doi">10.1038/s41564-021-00920-0</pub-id>.<pub-id pub-id-type="pmid">34226711</pub-id></mixed-citation>
    </ref>
    <ref id="R54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Qin</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota</article-title>. <source><italic toggle="yes">Nat. Commun.</italic></source>, <volume>4</volume>, <page-range>2151</page-range>.doi: <pub-id pub-id-type="doi">10.1038/ncomms3151</pub-id>.</mixed-citation>
    </ref>
    <ref id="R55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>The abundance of antibiotic resistance genes in human guts has correlation to the consumption of antibiotics in animal</article-title>. <source><italic toggle="yes">Gut Microbes</italic></source>, <volume>5</volume>, <fpage>245</fpage>–<lpage>249</lpage>.doi: <pub-id pub-id-type="doi">10.4161/gmic.27916</pub-id>.<pub-id pub-id-type="pmid">24637798</pub-id></mixed-citation>
    </ref>
    <ref id="R56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Kraker</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Stewardson</surname><given-names>A.J.</given-names></string-name> and <string-name><surname>Harbarth</surname><given-names>S.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Will 10 million people die a year due to antimicrobial resistance by 2050?</article-title><source><italic toggle="yes">PLoS Med.</italic></source>, <volume>13</volume>, <page-range>e1002184</page-range>.doi: <pub-id pub-id-type="doi">10.1371/journal.pmed.1002184</pub-id>.</mixed-citation>
    </ref>
    <ref id="R57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wittouck</surname><given-names>S.</given-names></string-name>, <string-name><surname>Salvetti</surname><given-names>E.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae</article-title>. <source><italic toggle="yes">Int. J. Syst. Evol. Microbiol.</italic></source>, <volume>70</volume>, <fpage>2782</fpage>–<lpage>2858</lpage>.doi: <pub-id pub-id-type="doi">10.1099/ijsem.0.004107</pub-id>.<pub-id pub-id-type="pmid">32293557</pub-id></mixed-citation>
    </ref>
    <ref id="R58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doron</surname><given-names>S.</given-names></string-name> and <string-name><surname>Snydman</surname><given-names>D.R.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Risk and safety of probiotics</article-title>. <source><italic toggle="yes">Clin. Infect. Dis.</italic></source>, <volume>60</volume>, <fpage>S129</fpage>–<lpage>S134</lpage>.doi: <pub-id pub-id-type="doi">10.1093/cid/civ085</pub-id>.<pub-id pub-id-type="pmid">25922398</pub-id></mixed-citation>
    </ref>
    <ref id="R59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lerner</surname><given-names>A.</given-names></string-name>, <string-name><surname>Shoenfeld</surname><given-names>Y.</given-names></string-name> and <string-name><surname>Matthias</surname><given-names>T.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Probiotics: if it does not help it does not do any harm. Really?</article-title><source><italic toggle="yes">Microorganisms</italic></source>, <volume>7</volume>, <page-range>104</page-range>.doi: <pub-id pub-id-type="doi">10.3390/microorganisms7040104</pub-id>.</mixed-citation>
    </ref>
    <ref id="R60">
      <label>60.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salvetti</surname><given-names>E.</given-names></string-name> and <string-name><surname>O’Toole</surname><given-names>P.W.</given-names></string-name></person-group> (<year>2017</year>) <article-title>When regulation challenges innovation: the case of the genus Lactobacillus</article-title>. <source><italic toggle="yes">Trends Food Sci. Technol.</italic></source>, <volume>66</volume>, <fpage>187</fpage>–<lpage>194</lpage>.doi: <pub-id pub-id-type="doi">10.1016/j.tifs.2017.05.009</pub-id>.</mixed-citation>
    </ref>
    <ref id="R61">
      <label>61.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sotoudegan</surname><given-names>F.</given-names></string-name>, <string-name><surname>Daniali</surname><given-names>M.</given-names></string-name>, <string-name><surname>Hassani</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>Reappraisal of probiotics’ safety in human</article-title>. <source><italic toggle="yes">Food Chem. Toxicol.</italic></source>, <volume>129</volume>, <fpage>22</fpage>–<lpage>29</lpage>.doi: <pub-id pub-id-type="doi">10.1016/j.fct.2019.04.032</pub-id>.<pub-id pub-id-type="pmid">31009735</pub-id></mixed-citation>
    </ref>
    <ref id="R62">
      <label>62.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Didari</surname><given-names>T.</given-names></string-name>, <string-name><surname>Solki</surname><given-names>S.</given-names></string-name>, <string-name><surname>Mozaffari</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>A systematic review of the safety of probiotics</article-title>. <source><italic toggle="yes">Expert Opin. Drug Saf.</italic></source>, <volume>13</volume>, <fpage>227</fpage>–<lpage>239</lpage>.doi: <pub-id pub-id-type="doi">10.1517/14740338.2014.872627</pub-id>.<pub-id pub-id-type="pmid">24405164</pub-id></mixed-citation>
    </ref>
    <ref id="R63">
      <label>63.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reid</surname><given-names>G.</given-names></string-name></person-group> (<year>2012</year>) <article-title>Microbiology: categorize probiotics to speed research</article-title>. <source><italic toggle="yes">Nature</italic></source>, <volume>485</volume>, <page-range>446</page-range>.doi: <pub-id pub-id-type="doi">10.1038/485446a</pub-id>.</mixed-citation>
    </ref>
    <ref id="R64">
      <label>64.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zven</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Susi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Mitre</surname><given-names>E.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Association between use of multiple classes of antibiotic in infancy and allergic disease in childhood</article-title>. <source><italic toggle="yes">JAMA Pediatr.</italic></source>, <volume>174</volume>, <fpage>199</fpage>–<lpage>200</lpage>.doi: <pub-id pub-id-type="doi">10.1001/jamapediatrics.2019.4794</pub-id>.<pub-id pub-id-type="pmid">31860016</pub-id></mixed-citation>
    </ref>
    <ref id="R65">
      <label>65.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Love</surname><given-names>B.L.</given-names></string-name>, <string-name><surname>Mann</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Hardin</surname><given-names>J.W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>Antibiotic prescription and food allergy in young children</article-title>. <source><italic toggle="yes">Allergy Asthma Clin. Immunol.</italic></source>, <volume>12</volume>, <page-range>41</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s13223-016-0148-7</pub-id>.</mixed-citation>
    </ref>
    <ref id="R66">
      <label>66.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Antibiotic-induced gut microbiota dysbiosis damages the intestinal barrier, increasing food allergy in adult mice</article-title>. <source><italic toggle="yes">Nutrients</italic></source>, <volume>13</volume>, <page-range>3315</page-range>.doi: <pub-id pub-id-type="doi">10.3390/nu13103315</pub-id>.</mixed-citation>
    </ref>
    <ref id="R67">
      <label>67.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tegegne</surname><given-names>B.S.</given-names></string-name>, <string-name><surname>Mengesha</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Teferra</surname><given-names>A.A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Syst. Rev.</italic></source>, <volume>7</volume>, <page-range>161</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s13643-018-0828-0</pub-id>.</mixed-citation>
    </ref>
    <ref id="R68">
      <label>68.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Su</surname><given-names>G.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Riggi</surname><given-names>E.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Association of kidney function with infections by multidrug-resistant organisms: an electronic medical record analysis</article-title>. <source><italic toggle="yes">Sci. Rep.</italic></source>, <volume>8</volume>, <page-range>13372</page-range>.doi: <pub-id pub-id-type="doi">10.1038/s41598-018-31612-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="R69">
      <label>69.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Beyrer</surname><given-names>C.</given-names></string-name> and <string-name><surname>Pozniak</surname><given-names>A.</given-names></string-name></person-group> (<year>2017</year>) <article-title>HIV drug resistance - an emerging threat to epidemic control</article-title>. <source><italic toggle="yes">N. Engl. J. Med.</italic></source>, <volume>377</volume>, <fpage>1605</fpage>–<lpage>1607</lpage>.doi: <pub-id pub-id-type="doi">10.1056/NEJMp1710608</pub-id>.<pub-id pub-id-type="pmid">29069566</pub-id></mixed-citation>
    </ref>
    <ref id="R70">
      <label>70.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Manosuthi</surname><given-names>W.</given-names></string-name>, <string-name><surname>Charoenpong</surname><given-names>L.</given-names></string-name> and <string-name><surname>Santiwarangkana</surname><given-names>C.</given-names></string-name></person-group> (<year>2021</year>) <article-title>A retrospective study of survival and risk factors for mortality among people living with HIV who received antiretroviral treatment in a resource-limited setting</article-title>. <source><italic toggle="yes">AIDS Res. Ther.</italic></source>, <volume>18</volume>, <page-range>71</page-range>.doi: <pub-id pub-id-type="doi">10.1186/s12981-021-00397-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="R71">
      <label>71.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhaskaran</surname><given-names>K.</given-names></string-name>, <string-name><surname>Rentsch</surname><given-names>C.T.</given-names></string-name>, <string-name><surname>MacKenna</surname><given-names>B.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform</article-title>. <source><italic toggle="yes">Lancet HIV</italic></source>, <volume>8</volume>, <fpage>e24</fpage>–<lpage>e32</lpage>.doi: <pub-id pub-id-type="doi">10.1016/S2352-3018(20)30305-2</pub-id>.<pub-id pub-id-type="pmid">33316211</pub-id></mixed-citation>
    </ref>
    <ref id="R72">
      <label>72.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cunningham</surname><given-names>M.</given-names></string-name>, <string-name><surname>Azcarate-Peril</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Barnard</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Shaping the future of probiotics and prebiotics</article-title>. <source><italic toggle="yes">Trends Microbiol.</italic></source>, <volume>29</volume>, <fpage>667</fpage>–<lpage>685</lpage>.doi: <pub-id pub-id-type="doi">10.1016/j.tim.2021.01.003</pub-id>.<pub-id pub-id-type="pmid">33551269</pub-id></mixed-citation>
    </ref>
    <ref id="R73">
      <label>73.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Day</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Harper</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Woods</surname><given-names>R.M.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>Probiotics: current landscape and future horizons</article-title>. <source><italic toggle="yes">Future Sci. OA</italic></source>, <volume>5</volume>, <page-range>FSO391</page-range>.doi: <pub-id pub-id-type="doi">10.4155/fsoa-2019-0004</pub-id>.</mixed-citation>
    </ref>
    <ref id="R74">
      <label>74.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>El Hage</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hernandez-Sanabria</surname><given-names>E.</given-names></string-name> and <string-name><surname>Van de Wiele</surname><given-names>T.</given-names></string-name></person-group> (<year>2017</year>) <article-title>Emerging trends in “smart probiotics”: functional consideration for the development of novel health and industrial applications</article-title>. <source><italic toggle="yes">Front. Microbiol.</italic></source>, <volume>8</volume>, <page-range>1889</page-range>.doi: <pub-id pub-id-type="doi">10.3389/fmicb.2017.01889</pub-id>.</mixed-citation>
    </ref>
    <ref id="R75">
      <label>75.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abid</surname><given-names>R.</given-names></string-name>, <string-name><surname>Waseem</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ali</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2022</year>) <article-title>Probiotic yeast Saccharomyces: back to nature to improve human health</article-title>. <source><italic toggle="yes">J. Fungi</italic></source>, <volume>8</volume>, <page-range>444</page-range>.doi: <pub-id pub-id-type="doi">10.3390/jof8050444</pub-id>.</mixed-citation>
    </ref>
    <ref id="R76">
      <label>76.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sen</surname><given-names>S.</given-names></string-name> and <string-name><surname>Mansell</surname><given-names>T.J.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Yeasts as probiotics: mechanisms, outcomes, and future potential</article-title>. <source><italic toggle="yes">Fungal Genet. Biol.</italic></source>, <volume>137</volume>, <page-range>103333</page-range>.doi: <pub-id pub-id-type="doi">10.1016/j.fgb.2020.103333</pub-id>.</mixed-citation>
    </ref>
    <ref id="R77">
      <label>77.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Daniali</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nikfar</surname><given-names>S.</given-names></string-name> and <string-name><surname>Abdollahi</surname><given-names>M.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Antibiotic resistance propagation through probiotics</article-title>. <source><italic toggle="yes">Expert Opin. Drug Metab. Toxicol.</italic></source>, <volume>16</volume>, <fpage>1207</fpage>–<lpage>1215</lpage>.doi: <pub-id pub-id-type="doi">10.1080/17425255.2020.1825682</pub-id>.<pub-id pub-id-type="pmid">32938241</pub-id></mixed-citation>
    </ref>
    <ref id="R78">
      <label>78.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rozman</surname><given-names>V.</given-names></string-name>, <string-name><surname>Mohar Lorbeg</surname><given-names>P.</given-names></string-name>, <string-name><surname>Accetto</surname><given-names>T.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Characterization of antimicrobial resistance in lactobacilli and bifidobacteria used as probiotics or starter cultures based on integration of phenotypic and in silico data</article-title>. <source><italic toggle="yes">Int. J. Food Microbiol.</italic></source>, <volume>314</volume>, <page-range>108388</page-range>.doi: <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2019.108388</pub-id>.</mixed-citation>
    </ref>
  </ref-list>
</back>
